Australia markets open in 4 hours 55 minutes

Mind Medicine (MindMed) Inc. (MNMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.87+0.38 (+4.48%)
As of 03:05PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 610.20M
Enterprise value 372.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.11
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.48
52-week change 3169.52%
S&P500 52-week change 326.16%
52-week high 312.22
52-week low 32.41
50-day moving average 39.33
200-day moving average 35.11

Share statistics

Avg vol (3-month) 32.44M
Avg vol (10-day) 31.24M
Shares outstanding 571.87M
Implied shares outstanding 671.87M
Float 833.26M
% held by insiders 12.67%
% held by institutions 125.28%
Shares short (15 Apr 2024) 46.92M
Short ratio (15 Apr 2024) 42.84
Short % of float (15 Apr 2024) 49.88%
Short % of shares outstanding (15 Apr 2024) 49.82%
Shares short (prior month 15 Mar 2024) 45.87M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 327 Feb 2020
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 329 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-39.84%
Return on equity (ttm)-83.59%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-95.73M
Diluted EPS (ttm)-2.44
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)99.7M
Total cash per share (mrq)2.41
Total debt (mrq)14.13M
Total debt/equity (mrq)18.08%
Current ratio (mrq)3.22
Book value per share (mrq)1.90

Cash flow statement

Operating cash flow (ttm)-64.36M
Levered free cash flow (ttm)-25.91M